166 related articles for article (PubMed ID: 28856973)
1. The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura.
Ellithy HN; Ahmed SH; Shahin GH; Matter MM; Talatt M
Hematology; 2018 Apr; 23(3):169-174. PubMed ID: 28856973
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance].
Zhu Y; Zhuang Y; Yang GH; Qiang XF; Yang L; Shen YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):135-9. PubMed ID: 23484707
[TBL] [Abstract][Full Text] [Related]
3. FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt.
Eyada TK; Farawela HM; Khorshied MM; Shaheen IA; Selim NM; Khalifa IA
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):64-8. PubMed ID: 22123287
[TBL] [Abstract][Full Text] [Related]
4. Fcγ receptor gene polymorphisms in childhood immune thrombocytopenic purpura.
Amorim DM; Silveira Vda S; Scrideli CA; Queiroz RG; Tone LG
J Pediatr Hematol Oncol; 2012 Jul; 34(5):349-52. PubMed ID: 22713706
[TBL] [Abstract][Full Text] [Related]
5. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
Cooper N; Stasi R; Cunningham-Rundles S; Cesarman E; McFarland JG; Bussel JB
Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462
[TBL] [Abstract][Full Text] [Related]
6. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.
Pehlivan M; Okan V; Sever T; Balci SO; Yilmaz M; Babacan T; Pehlıvan S
Platelets; 2011; 22(8):588-95. PubMed ID: 21591983
[TBL] [Abstract][Full Text] [Related]
7. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.
Carcao MD; Blanchette VS; Wakefield CD; Stephens D; Ellis J; Matheson K; Denomme GA
Br J Haematol; 2003 Jan; 120(1):135-41. PubMed ID: 12492589
[TBL] [Abstract][Full Text] [Related]
8. Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia.
Burkhardt B; Yavuz D; Zimmermann M; Schieferstein J; Kabickova E; Attarbaschi A; Lisfeld J; Reiter A; Makarova O; Worch J; Bonn BR; Damm-Welk C
Ann Hematol; 2016 Sep; 95(9):1503-12. PubMed ID: 27376362
[TBL] [Abstract][Full Text] [Related]
9. FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome.
Papagianni A; Economou M; Tragiannidis A; Karatza E; Samarah F; Gombakis N; Athanassiadou-Piperopoulou F; Vavatsi-Christaki N; Athanassiou-Metaxa M
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):35-9. PubMed ID: 23249566
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura.
Fujimoto TT; Inoue M; Shimomura T; Fujimura K
Br J Haematol; 2001 Oct; 115(1):125-30. PubMed ID: 11722422
[TBL] [Abstract][Full Text] [Related]
11. Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.
Bibeau F; Lopez-Crapez E; Di Fiore F; Thezenas S; Ychou M; Blanchard F; Lamy A; Penault-Llorca F; Frébourg T; Michel P; Sabourin JC; Boissière-Michot F
J Clin Oncol; 2009 Mar; 27(7):1122-9. PubMed ID: 19164213
[TBL] [Abstract][Full Text] [Related]
12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
13. Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.
Hatjiharissi E; Hansen M; Santos DD; Xu L; Leleu X; Dimmock EW; Ho AW; Hunter ZR; Branagan AR; Patterson CJ; Kortsaris A; Verselis S; Fox E; Treon SP
Clin Lymphoma Myeloma; 2007 Jan; 7(4):286-90. PubMed ID: 17324336
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
15. Correlation of FcγRIIIa Polymorphisms to the Response of Rituximab in Thai Patients with Diffuse Large B-Cell Lymphoma.
Angsirisak N; Wittayalertpanya S; Limpanasithikul W; Bunworasate U; Owattanapanich D
J Med Assoc Thai; 2015 Dec; 98(12):1215-21. PubMed ID: 27004307
[TBL] [Abstract][Full Text] [Related]
16. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
Cooper N; Heddle NM; Haas M; Reid ME; Lesser ML; Fleit HB; Woloski BM; Bussel JB
Br J Haematol; 2004 Feb; 124(4):511-8. PubMed ID: 14984503
[TBL] [Abstract][Full Text] [Related]
17. FCGR2A rs1801274 polymorphism is associated with risk of childhood-onset idiopathic (immune) thrombocytopenic purpura: evidence from a meta-analysis.
Wang D; Hu SL; Cheng XL; Yang JY
Thromb Res; 2014 Dec; 134(6):1323-7. PubMed ID: 25457587
[TBL] [Abstract][Full Text] [Related]
18. Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori.
Suzuki T; Matsushima M; Shirakura K; Koike J; Masui A; Takagi A; Shirasugi Y; Ogawa Y; Shirai T; Mine T
Digestion; 2008; 77(2):73-8. PubMed ID: 18354254
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.
Al Askar AS; Shaheen NA; Al Zahrani M; Al Otaibi MG; Al Qahtani BS; Ahmed F; Al Zughaibi M; Kamran I; Mendoza MA; Khan A
Int J Hematol; 2018 Jan; 107(1):69-74. PubMed ID: 28895035
[TBL] [Abstract][Full Text] [Related]
20. Relation of interleukin-10 Promoter Polymorphisms to Adult Chronic Immune Thrombocytopenic Purpura in a Cohort of Egyptian Population.
El Ghannam D; Fawzy IM; Azmy E; Hakim H; Eid I
Immunol Invest; 2015; 44(7):616-26. PubMed ID: 26436850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
